Neurotronic to Present First Clinical Outcomes for...
Category : Clinical Trial Update 25 October 2025Neurotronic, Inc., a U.S.-based medical technology company developing multi-organ denervation therap...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Johnson & Johnson Reports Positive Phase 2 Results...
Category : Clinical Trial Update 25 October 2025Johnson & Johnson (NYSE: JNJ) announced that nipocalimab, its first-in-class FcRn inhibitor, met...
Halia Therapeutics Receives FDA Orphan Drug Design...
Category : ODD/BTA/FTA Status 25 October 2025Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on therapies that targe...
GSK Reports Positive Phase III Results for Low-Car...
Category : Clinical Trial Update 24 October 2025GSK plc has announced positive phase III results from its clinical programme evaluating a next-gener...
Novartis Reports Positive Phase III Results for Co...
Category : Clinical Trial Update 24 October 2025Novartis announced that its biologic therapy Cosentyx (secukinumab) achieved the primary endpoint an...
Latest Newsletter Post
-
Halia Therapeutics Receives FDA Orp..
25 October 2025
-
Johnson & Johnson Reports Positive..
25 October 2025
-
Neurotronic to Present First Clinic..
25 October 2025
-
CAGE Bio Initiates Clinical Trial f..
24 October 2025
-
FDA Grants Fast Track Designation t..
24 October 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com